Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

BACKGROUND: Sodium–glucose cotransporter 2 inhibitors reduce hospitalizations for heart failure and cardiovascular death, although the underlying mechanisms have not been resolved. The SIMPLE trial (The Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jürgens, Mikkel, Schou, Morten, Hasbak, Philip, Kjær, Andreas, Wolsk, Emil, Zerahn, Bo, Wiberg, Mikkel, Brandt‐Jacobsen, Niels H., Gæde, Peter, Rossing, Peter, Faber, Jens, Inzucchi, Silvio E., Gustafsson, Finn, Kistorp, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475664/
https://www.ncbi.nlm.nih.gov/pubmed/34278803
http://dx.doi.org/10.1161/JAHA.120.020418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475664/
https://www.ncbi.nlm.nih.gov/pubmed/34278803
http://dx.doi.org/10.1161/JAHA.120.020418

Ejemplares similares